Td Private Client Wealth LLC Moderna, Inc. Transaction History
Td Private Client Wealth LLC
- $3.48 Trillion
- Q3 2024
A detailed history of Td Private Client Wealth LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 339 shares of MRNA stock, worth $14,709. This represents 0.0% of its overall portfolio holdings.
Number of Shares
339
Previous 559
39.36%
Holding current value
$14,709
Previous $66.4 Million
65.87%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding MRNA
# of Institutions
953Shares Held
241MCall Options Held
10.6MPut Options Held
18.7M-
Baillie Gifford & CO42.5MShares$1.84 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.75 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.11 Billion0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$731 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$314 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $17B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...